WHO ICTRP trial
Diagnostic Concordance of CXCR4-PET/CT and Adrenal Vein Sampling in Subtyping…
ChiCTR2600118245 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2600118245 |
|---|---|
| Public title | Diagnostic Concordance of CXCR4-PET/CT and Adrenal Vein Sampling in Subtyping Primary Aldosteronism and Its Guiding Value for Percutaneous Adrenal Artery Embolization: A Prospective Observational Study |
| Scientific title | Diagnostic Concordance of CXCR4-PET/CT and Adrenal Vein Sampling in Subtyping Primary Aldosteronism and Its Guiding Value for Percutaneous Adrenal Artery Embolization: A Prospective Observational Study |
| Primary sponsor | Lanzhou University Second Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Diagnostic test |
| Countries | China |
| Conditions | Primary aldosteronism (PA) is the most common cause of secondary hypertension, accounting for up to 10% of hypertensive patients and an even higher proportion among those with resistant hypertension . Characterized by autonomous aldosterone… |
| Interventions | Gold Standard:In individuals with primary aldosteronism (PA) considering surgery, we suggest adrenal lateralization with computed tomography (CT) scanning and adrenal venous sampling (AVS) prior to deciding the treatment approach (medical… |
| Registration date | Feb 3, 2026 |
| Target size | Target condition:154;Difficult condition:5 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: